Overview
Oropouche virus (OROV) is an emerging arbovirus causing significant public health concern in Latin America, particularly in the Amazon region of Brazil, with increasing case reports in recent years 1. No licensed vaccines or antiviral therapies are currently available for OROV infection.Diagnosis
Clinical presentation includes fever, headache, myalgia, arthralgia, and maculopapular rash 1.
Laboratory diagnosis typically involves serological testing (e.g., IgM ELISA) and molecular methods (RT-PCR) to detect viral RNA 1.
Differential diagnosis should consider other arboviral infections prevalent in the region 1.Management
Supportive care is the mainstay of treatment, including hydration, antipyretics, and analgesics as needed 1.
There are no specific antiviral therapies recommended for OROV infection 1.
Close monitoring for complications such as encephalitis or hemorrhagic manifestations is advised 1.Special Populations
No specific management guidelines provided for pregnancy, pediatrics, elderly, or patients with comorbidities based on the available abstracts 1.Key Recommendations
Implement supportive care measures including hydration and symptomatic treatment with antipyretics and analgesics for managing OROV infection (Evidence: Expert opinion 1).
Utilize serological testing (IgM ELISA) and molecular diagnostics (RT-PCR) for accurate diagnosis of OROV infection (Evidence: Expert opinion 1).
Monitor patients closely for potential complications such as neurological symptoms, given the lack of specific antiviral treatments (Evidence: Expert opinion 1).References
1 Naveed M, Athar A, Tariq A, Asim M, Majeed MN, El Hadi Mohamed RA et al.. Immunoinformatics-guided design of a multi-epitope vaccine targeting the envelopment polyprotein of oropouche virus. Molecular genetics and genomics : MGG 2026. link